Persistent CMV infection after allogeneic hematopoietic stem cell transplantation in a CMV-seronegative donor-to-positive recipient constellation: Development of multidrug resistance in the absence of anti-viral cellular immunity-Reference-Cited by-同舟云学术

Persistent CMV infection after allogeneic hematopoietic stem cell transplantation in a CMV-seronegative donor-to-positive recipient constellation: Development of multidrug resistance in the absence of anti-viral cellular immunity

Published:2016-01 Issue: Volume:74 Page:57-60
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Herling Marco,Schröder L.,Awerkiew Sabine,Chakupurakal Geothy,Holtick Udo,Kaiser Rolf,Pfister Herbert,Scheid Christof,Di Cristanziano Veronica

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference26 articles.

1. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines;Peggs;Lancet,2013

2. Accelerating immune reconstitution after hematopoietic stem cell transplantation;Tzannou;Clin. Transl. Immunol.,2014

3. Cytomegalovirus infection/disease after hematopoietic stem cell transplantation;Mori;Int. J. Hematol.,2010

4. Immunobiology of human cytomegalovirus: from bench to bedside;Crough;Clin. Microbiol. Rev.,2009

5. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments;Cihlar;J. Virol.,1998

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality;Bone Marrow Transplantation;2023-03-03

2. Cytomegalovirus infection is associated with rapid NK differentiation and reduced incidence of relapse in HLA matched sibling donor transplant patients;Clinical and Experimental Immunology;2022-11-16

3. Combined Therapy with Intravenous Immunoglobulins, Letermovir and (Val-)Ganciclovir in Complicated Courses of CMV-Infection in Transplant Recipients;Microorganisms;2021-08-04

4. Make Sure You Have a Safety Net: Updates in the Prevention and Management of Infectious Complications in Stem Cell Transplant Recipients;Journal of Clinical Medicine;2020-03-21

5. Antiviral Agents as Therapeutic Strategies Against Cytomegalovirus Infections;Viruses;2019-12-23